Challenges in the quantification approach to a radiation relevant adverse outcome pathway for lung cancer.


Journal

International journal of radiation biology
ISSN: 1362-3095
Titre abrégé: Int J Radiat Biol
Pays: England
ID NLM: 8809243

Informations de publication

Date de publication:
2021
Historique:
pubmed: 11 9 2020
medline: 26 8 2021
entrez: 10 9 2020
Statut: ppublish

Résumé

Adverse outcome pathways (AOPs) provide a modular framework for describing sequences of biological key events (KEs) and key event relationships (KERs) across levels of biological organization. Empirical evidence across KERs can support construction of quantified AOPs (qAOPs). Using an example AOP of energy deposition from ionizing radiation onto DNA leading to lung cancer incidence, we investigate the feasibility of quantifying data from KERs supported by all types of stressors. The merits and challenges of this process in the context of AOP construction are discussed. Empirical evidence across studies of dose-response from four KERs of the AOP were compiled independently for quantification. Three upstream KERs comprised of evidence from various radiation types in line with AOP guidelines. For these three KERs, a focused analysis of data from alpha-particle studies was undertaken to better characterize the process to the adverse outcome (AO) for a radon gas stressor. Numerical information was extracted from tables and graphs to plot and tabulate the response of KEs. To complement areas of the AOP quantification process, Monte Carlo (MC) simulations in TOPAS-nBio were performed to model exposure conditions relevant to the AO for an example bronchial compartment of the lung with secretory cell nuclei targets. Quantification of AOP KERs highlighted the relevance of radiation types under the stressor-agnostic intent of AOP design, motivating a focus on specific types. For a given type, significant differences of KE response indicate meaningful data to derive linkages from the MIE to the AO is lacking and that better response-response focused studies are required. The MC study estimates the linear energy transfer (LET) of alpha-particles emitted by radon-222 and its progeny in the secretory cell nuclei of the example lung compartment to range from Quantifying AOP components provides a means to assemble empirical evidence across different studies. This highlights challenges in the context of studies examining similar endpoints using different radiation types. Data linking KERs to a MIE of 'deposition of energy' is shown to be non-compatible with the stressor-agnostic principles of AOP design. Limiting data to that describing response-response relationships between adjacent KERs may better delineate studies relevant to the damage that drives a pathway to the next KE and still support an 'all hazards' approach. Such data remains limited and future investigations in the radiation field may consider this approach when designing experiments and reporting their results and outcomes.

Identifiants

pubmed: 32909875
doi: 10.1080/09553002.2020.1820096
pmc: PMC7864104
mid: NIHMS1660113
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

85-101

Subventions

Organisme : NCI NIH HHS
ID : R01 CA187003
Pays : United States

Références

Clin Exp Optom. 2004 Nov;87(6):377-85
pubmed: 15575811
Health Phys. 2009 Nov;97(5):394-406
pubmed: 19820449
Radiat Res. 2010 May;173(5):677-88
pubmed: 20426668
Biophys J. 2000 Jul;79(1):184-90
pubmed: 10866946
Environ Toxicol Chem. 2019 Sep;38(9):1850-1865
pubmed: 31127958
Sci Rep. 2017 Mar 27;7:45161
pubmed: 28345622
Radiat Res. 2001 Nov;156(5 Pt 2):577-83
pubmed: 11604075
Int J Radiat Biol. 2020 Jun;96(6):767-778
pubmed: 32052675
Toxicol Sci. 2017 Feb;155(2):326-336
pubmed: 27994170
Int J Radiat Biol. 1989 Jul;56(1):1-19
pubmed: 2569005
Ann ICRP. 1994;24(1-3):1-482
pubmed: 7726471
Phys Med Biol. 2018 Sep 06;63(17):175018
pubmed: 30088810
Curr Environ Health Rep. 2016 Mar;3(1):53-63
pubmed: 26809562
Health Phys. 2015 Feb;108(2):125-30
pubmed: 25551492
Cancers (Basel). 2020 Mar 26;12(4):
pubmed: 32225023
Radiat Environ Biophys. 2004 Dec;43(4):247-56
pubmed: 15645313
Ann ICRP. 2007;37(2-4):1-332
pubmed: 18082557
Mutat Res. 2011 Jun 3;711(1-2):28-40
pubmed: 21281649
Environ Toxicol Chem. 2010 Mar;29(3):730-41
pubmed: 20821501
Med Phys. 2018 Jun 14;:
pubmed: 29901835
Phys Med. 2015 Dec;31(8):861-874
pubmed: 26653251
Med Phys. 2012 Nov;39(11):6818-37
pubmed: 23127075
Toxicol Sci. 2014 Dec;142(2):312-20
pubmed: 25466378
Med Phys. 2010 Sep;37(9):4692-708
pubmed: 20964188
Radiat Environ Biophys. 2004 Sep;43(3):153-63
pubmed: 15316819
Oncol Rep. 2012 Mar;27(3):769-74
pubmed: 22200791
Phys Med Biol. 2015 Nov 7;60(21):8249-74
pubmed: 26449929
Life (Basel). 2014 Sep 11;4(3):491-510
pubmed: 25370382
Radiat Res. 2019 Feb;191(2):125-138
pubmed: 30609382
Phys Med. 2018 Jul;51:108-116
pubmed: 29908994
Int J Radiat Biol. 2021;97(1):68-84
pubmed: 31846388

Auteurs

Robert Stainforth (R)

Radiation Protection Bureau, Health Canada, Ottawa, Canada.

Jan Schuemann (J)

Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Aimee L McNamara (AL)

Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Ruth C Wilkins (RC)

Consumer and Clinical Radiation Protection Bureau, Health Canada, Ottawa, Canada.

Vinita Chauhan (V)

Consumer and Clinical Radiation Protection Bureau, Health Canada, Ottawa, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH